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Abstract
Porous magnesium implants are of particular interest for application as resorbable bone
substitutes, due to their mechanical strength and a Young’s modulus similar to bone. The objective
of the present study was to compare the biocompatibility, bone and tissue ingrowth, and the
degradation behaviour of scaffolds made from the magnesium alloys LAE442 (n= 40) and Mg-La2
(n= 40) in vivo. For this purpose, cylindrical magnesium scaffolds (diameter 4 mm, length 5 mm)
with defined, interconnecting pores were produced by investment casting and coated with MgF2.
The scaffolds were inserted into the cancellous part of the greater trochanter ossis femoris of
rabbits. After implantation periods of 6, 12, 24 and 36 weeks, the bone-scaffold compounds were
evaluated using ex vivo µCT80 images, histological examinations and energy dispersive x-ray
spectroscopy analysis. The La2 scaffolds showed inhomogeneous and rapid degradation, with
inferior osseointegration as compared to LAE442. For the early observation times, no bone and
tissue could be observed in the pores of La2. Furthermore, the excessive amount of foreign body
cells and fibrous capsule formation indicates insufficient biocompatibility of the La2 scaffolds. In
contrast, the LAE442 scaffolds showed slow degradation and better osseointegration. Good
vascularization, a moderate cellular response, bone and osteoid-like bone matrix at all
implantation periods were observed in the pores of LAE442. In summary, porous LAE442 showed
promise as a degradable scaffold for bone defect repair, based on its degradation behaviour and
biocompatibility. However, further studies are needed to show it would have the necessary
mechanical properties required over time for weight-bearing bone defects.
1. Introduction
Currently, the treatment of large bone defects caused
by trauma, infection or tumour constitute a serious
medical problem, especially when defects of critical
size lack the ability to heal and impaired bone heal-
ing occurs [1, 2]. Although autografts are the gold
standard for the treatment of these defects, they are
associated with the problems of limited availability,
additional surgery and postoperative complications
[3, 4]. For this reason, there is a great demand in
orthopaedic surgery for alternatives to bone grafts
for bone defects. Although the use of porous ceram-
ics and polymers as degradable bone substitutes were
some of the first implantable biomaterials, the use
of degradable porous metals has become a focus of
research in recent years [5–7].
Degradable bone substitutes should preferably
have an osteoinductive and osteoconductive effect,
as well as a good long-term biocompatibility and a
degradation rate adapted to the formation of new
bone [4, 5]. For successful osseointegration of scaf-
folds, certain structural properties such as high poros-
ity, suitable pore size, and interconnecting pores are
of particular importance [4, 8, 9]. The pores have
a great influence on the immigration and ingrowth
of cells and blood vessels, as well as for ensuring
the nutritive supply to the ingrowing tissue. Scaffolds
© 2021 The Author(s). Published by IOP Publishing Ltd
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with macropores between 150 and 500 µm proved to
be particularly advantageous [5, 10, 11].
In addition, although it depends on the
application and the stabilization technique, the bone
substitutes should have similar mechanical proper-
ties to bone, both in the area of the defect and at the
attachment to the surrounding bone. Current porous
bone substitutes made of polymers or ceramics, such
as β-tricalcium phosphate (TCP), can show good
biocompatibility and osseointegration, but have low
mechanical stability, so they are mainly used to fill
smaller defects or are applied as coatings [12, 13]. For
effective treatment of long tubular bone defects, cyl-
indrical titanium mesh cages combined with a bone
graft have been used to repair critical size bone defects
[14, 15]. However, removal of the inserted titanium
mesh cage is not possible after it has been surrounded
by bone. Therefore, leaving the titanium mesh cages
in the bone may result in stress shielding, secondary
bone absorption and fracture [14, 16].
The resorbable metal magnesium and its alloys
have been investigated in numerous studies for ortho-
paedic use due to the positive properties in con-
text with biomedical application [13, 17, 18]. Among
these positive properties are a Young’s modulus sim-
ilar to bone [16, 17] and a significantly higher mech-
anical stability compared to polymers and ceramics
[13]. Furthermore,magnesium is an essential element
in the body and is involved in many metabolic and
enzymatic reactions [19]. However, the comparat-
ively rapid degradation and the associated accumula-
tion of hydrogen and corrosion products in aqueous
solution are the main disadvantages of magnesium-
based implants [13, 20, 21].
So far, most magnesium alloys have only been
investigated as solid implants with a comparably
small surface area available for corrosion. Thus, the
interaction with the host tissue and the bone to scaf-
fold interface could only be assessed to a limited
extent. In contrast, open porous implants provide
a larger surface area that can enhance osseointegra-
tion, but also increase the degradation rate. There-
fore, these scaffolds should consist of slowly degrad-
ing magnesium alloys to ensure sufficient mechanical
stability when used as a bone substitute [7]. In order
to control and reduce the rapid degradation, the res-
istance of magnesium alloys can be tailored by select-
ing appropriate alloying elements. Alloys containing
the elements aluminium (Al), lithium (Li), zinc and
rare earths (REs) have proven to be particularly res-
istant [22, 23]. Screws made of the magnesium alloy
MgYREZr (MAGNEZIX®) are already used in human
medicine [24, 25].
The magnesium alloy LAE442 contains Li, Al
and RE as alloying elements and has proven to be
very resistant and biocompatible in many in vitro
and in vivo studies in the form of intramedullary
pins, cylindrical solid bodies and screw–plate systems
[26–31]. The binary alloy Mg-La2 with lanthanum,
on the other hand, has only been tested in vitro so
far and has demonstrated an improved reproducib-
ility by using fewer alloy components [32]. In the
study by Weizbauer et al, the alloy showed good cell
compatibility and goodmaterial properties for in vivo
evaluation [32].
In addition, many studies have shown that coat-
ings or surface treatments of magnesium implants
have a corrosion retarding effect [33, 34]. Coating
with MgF2 showed a significant reduction in mag-
nesium degradation in the initial phase, and dir-
ect contact to the surrounding bone [35, 36]. Fur-
thermore, better attachment and proliferation of
cells could be achieved on MgF2-coated magnesium
implants compared to uncoated ones [37]. Compared
to microarc oxidation and other surface treatments,
MgF2 coating is a simple and cost-effective method
suitable for industrial production [38].
The production of reproducible, porous mag-
nesium scaffolds can be a challenge, since most man-
ufacturing techniques, such as powder metallurgy
technology, only achieve undefined pore structures
[6, 7, 39, 40]. However, with the investment casting
process it is possible to obtain defined interconnect-
ing pore structures of Mg-based scaffolds with a high
design flexibility [41].
Using this method, porous scaffolds made of the
alloys LAE442 andMg-La2were produced and invest-
igated by Julmi et al [42]. The in vitro tests showed suf-
ficient strength of the scaffolds to withstand the forces
in rabbit bone with a compression weight-bearing
capacity 3.4 times (La2) and 5.6 times (LAE442)
higher than the expected load [41, 42]. In the in vivo
study by Kleer et al the two magnesium scaffolds
LAE442 and La2 with defined interconnecting pores
and MgF2 coating were evaluated using regular radi-
ological and in vivo µCT images over a period of
36 weeks [43]. In this study, slow degradation beha-
viour for the LAE442 scaffolds and comparatively fast
degradation of the La2 scaffolds with higher gas pro-
duction could already be observed.
The objective of this study was to compare the
biocompatibility and the degradation mechanisms of
the porous magnesium scaffolds made of the alloys
LAE442 and Mg-La2 using high-resolution µCT80
images, histological examinations and SEM/energy
dispersive x-ray spectroscopy (EDX) analyses after an
implantation period of up to 36 weeks.
2. Materials andmethods
2.1. Scaffolds
For the present study, 80 cylindrical scaffolds
(ø 4 mm, length 5 mm), each with interconnecting
pores (max. pore size 500 µm, porosity 41.4%), were
produced from the magnesium alloys La2 (n = 40;
2 wt.% La) and LAE442 (n= 40; 4 wt.% Li, 4 wt.%Al,
2 wt.% REs) by investment casting [41]. The scaffolds
were coated with MgF2 using the conversion coating
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Figure 1. (a) Geometry of the scaffolds featuring five pores and five struts and (b) cross-section with outer and inner ring for
semi-quantitative analysis; (c) basic contour and (d) extended contour for quantitative analysis of µCT80 scans.
method (thickness between 450 and 1250 nm) and
sterilized by gamma radiation (>25 kGy, BBF Steril-
isation Service GmbH, Kernen, Germany). The pro-
duction process and theMgF2 coating of the scaffolds
is described in more detail in the literature [41]. A
total of 40 commercially available, porous β-TCP
implants (Cerasorb® M, Curasan AG, Kleinostheim,
Germany) with the same dimensions (ø 4mm, length
5 mm, total porosity 65%) served as a control group.
2.2. Animal model
The animal experiment was approved by the gov-
ernment of Upper Bavaria according to the Animal
Welfare Act (approval number: 55.2-1-54-2532-
181-2015). A total of 60 mature female Zika
rabbits (Asamhof, Kissing, Germany; Ø weight:
3.96 ± 0.27 kg, age: >6 months) were allocated to
time groups of 6, 12, 24 and 36 weeks. For each
time group, ten scaffolds of both magnesium alloys
and the TCP control group were randomly inser-
ted into the cancellous part of the trochanter major
ossis femoris of the rabbits. Using a 4 mm drill, an
approximately 6 mm deep hole was drilled into the
cancellous part of the greater trochanter and the scaf-
folds were inserted. The exact course of the surgical
procedure, as well as anaesthesia and postoperative
care, are described elsewhere [43]. After the respect-
ive implantation periods, the animals were sedated
with ketamine (15 mg kg−1, Anesektin®, Albrecht
GmbH, Aulendorf, Germany) and medetomidine
(0.25 mg kg−1, Dorbene vet®, Zoetis Deutschland
GmbH, Berlin, Germany), and euthanized by intra-
venous application of pentobarbital (182.3 mg kg−1,
Narkodorm®, CP-Pharma GmbH, Burgdorf,
Germany) for the ex vivo examinations.
2.3. Ex vivo µCT
Both femora were explanted, and all soft tissue was
removed to harvest the implantation sites with a dia-
mond band saw (Cut-grinder, patho-service GmbH,
Oststeinbek, Germany). For the following investig-
ations, the bone-scaffold compounds were fixed in
a 4% formaldehyde solution for at least 14 days
and positioned upright in plastic tubes fixed with
foam sponges. Subsequently, ex vivo µCT scans of
the bone-scaffold compounds were performed with
a µCT80 (Scanco Medical AG, Brüttisellen, Switzer-
land). The scan settings were: 600 ms, 70 kVp and
114 µA with a resolution of 10 µm. The scaffolds
were manually contoured in the original scans and
reoriented (Software µCT Evaluation Program V6.6,
Scanco Medical, Zurich, Switzerland) to improve the
comparability as the cross-sections allowed better
assessment of the scaffolds with their immediate sur-
roundings. In order to determine the degradation
of the magnesium scaffolds, scans were performed
before implantation with the same scan settings and
compared with the ex vivo scans.
2.3.1. Semi-quantitative analysis
A semi-quantitative scoring system modified
according to Lalk et alwas used to evaluate theµCT80
images of all scaffolds [44]. The parameters scaf-
fold degradation and scaffold shape, as well as the
parameters gas within and in the direct surround-
ings of the scaffolds were evaluated. In addition, the
structure of the surrounding cancellous bone was
assessed in two areas of the scaffolds (upper and lower
half of the scaffold). The integration of scaffold into
bone (bone-to-scaffold contact) was evaluated on ten
cross-sections (five pore and five strut levels each; cf
figure 1(a)). Based on these cross-sections, the bone
within the scaffolds was evaluated in an outer and an
inner ring (figure 1(b)). For the TCP control group,
the parameters degradation and scaffold shape were
not examined due to different material properties.
Score values ranged from 0 for physiological/original
to 4 for clearly altered (table 1).
2.3.2. Quantitative analysis
A threshold (LAE442 160, La2 186, TCP 360) was
determined for each material group and applied for
the subsequent evaluations. In order to calculate the
volume, density and surface area of the scaffolds after
the respective implantation period of 6, 12, 24 or
36weeks, the residual scaffolds in the reoriented scans
were manually contoured by excluding the ingrown
bone (basic contour; figure 1(c)). This analysis was
also performed for the magnesium scaffolds before
implantation to obtain the baseline values.
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Table 1. Scoring system for semi-quantitative µCT80 evaluation, modified according to Lalk et al [36].
Parameters Score 0 Score 1 Score 2 Score 3 Score 4
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No bone
In order to determine the amount of bone inside
the scaffolds, an extended contour was created based
on the exact scaffold rims (figure 1(d)). Therefore, the
difference between the extended and the basic con-
tour was defined as ingrown bone.
A total of seven scaffolds per material and time
group were quantitatively investigated. The analyses
were performed using µCT80 scans if scaffold mater-
ial could be detected and contoured. Otherwise, the
scans were assessed descriptively.
2.4. Histological examination
The bone-scaffold compounds were removed from
the 4% buffered formaldehyde solution and were
dehydrated in a series of increasingly concentrated
alcohol solutions, ending in 100%. Subsequently,
xylene served as the intermedium before the samples
were embedded in a plastic resin based on methyl
methacrylate (Technovit® 9100, Heraeus Kulzer,
Wehrheim, Germany). Using the cutting and grind-
ing technique according to Donath, cross-sections
of 70 µm thickness were produced [45]. A cent-
ral cross-section (level with pores not struts) of
each bone-scaffold compound was then stained
with toluidine blue O (Waldeck, Münster, Germany)
[46]. The histological examinations were performed
using a Zeiss Axio Imager 2 microscope (Carl Zeiss
Microscopy GmbH, Jena, Germany) and Zeiss ZEN2
software (Carl Zeiss Microscopy, Jena, Germany).
The samples were assessed semi-quantitatively
using a scoring system, whereby score values
between 0 and 3 were assigned for all parameters
(table 2).
At 25× magnification, a circle with a 4 mm
diameter was placed around the scaffolds and the
amount of scaffold material (total/cracked), bone,
non-mineralized bone matrix, granulation tissue and
gas were examined (figure 2). Furthermore, the para-
meters resorption of bone and fibrous capsule form-
ation in the immediate vicinity of the scaffolds were
assessed. For the evaluation of gas bubbles, the pres-
ence of thin fibrocyte borders was investigated to dis-
tinguish between bubbles formed in vivo by degrada-
tion and those formed by the preparation process.
Blood vessels and cells (fibrocytes, macrophages,
foreign body cells (FBCs), neutrophil granulocytes
and lymphocytes) were examined at 100× magnific-
ation in four areas: within a central, medial and peri-
pheral ring in the scaffold, and direct scaffold vicinity
(figure 2).
2.5. SEM/EDX
The in vitro and ex vivo degradation behaviour of the
two scaffolds LAE442 and La2 was already comparat-
ively investigated using SEM and EDX analysis in an
earlier study [2]. Based on these results and the his-
tological results from the present study, selected SEM
and EDX analyses were performed with a SUPRA 55
VP (Carl Zeiss AG, Oberkochen, Germany) to invest-
igate areas of special interest (degradation layer,MgF2
coating, bone-to-scaffold contact, cell clusters). An
acceleration voltage of 15 kV and a working distance
4
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Table 2. Scoring system for the histological evaluation of the bone-scaffold compound cross-sections.
Parameters Score 0 Score 1 Score 2 Score 3








Fibrous capsule None Mild Moderate Severe
Fibrous cells (tissue) None Few Moderate Many
Vascularization
(blood vessels)





Figure 2. Histological image of scaffold cross-section; evaluation at 25×magnification, subdivided in two areas: inside and
outside black circle (4 mm); evaluation at 100×magnification, subdivided in four areas: central ring (I), medial ring (II) and
peripheral ring (III), and direct scaffold vicinity (IV).
of 20–25mmfor the overview images and 7.8–9.8mm
for the close-up images were used. Carbon and oxy-
gen were excluded, as it is difficult to quantify their
amount by EDX analysis.
2.6. Statistics
The data were statistically evaluated using SPSS
Statistics 25.0. Since the data were not normally
distributed, Kruskal–Wallis tests were used for the
evaluation and a pairwise comparison was per-
formed with subsequent single-functional ANOVA.
Subsequently, adjustments were made using the Bon-
ferroni correction. Quantitative data on the degrad-
ation of the magnesium scaffolds were investigated
using the Mann–Whitney U-test. In all analyses, a
value of p < 0.05 was considered significant.
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Figure 3. µCT80 images of cross-sections; progression of degradation of the scaffolds after implantation periods of 6, 12, 24 or
36 weeks; (a)–(d) LAE442, (e)–(h) La2 and (i)–(l) TCP.
3. Results
3.1. Ex vivo µCT
3.1.1. Semi-quantitative µCT80 evaluations
Using µCT80 images, the exact degradation beha-
viour of the scaffolds as well as the ingrowth of bone
into the scaffolds were assessed (figure 3).
The LAE442 scaffolds showed an overall very slow
and homogeneous degradation. After 6 and 12 weeks,
only a thin degradation layer (score 1) was detected at
the edge of the scaffolds. The scaffold shape remained
unchanged (score 1) after 6 weeks and only slight
surface changes (score 1) occurred after 12 weeks of
implantation. After 24 and 36weeks, all LAE442 (with
one exception, week 24, score 1) showed a clearly
recognizable degradation layer with small, detached
parts of the scaffolds (score 2). Bright inhomo-
geneous areas could be observed after 6 weeks on
the LAE442 scaffolds (figure 4(a)), which increased
strongly in size andnumber until week 36. In contrast,
the La2 scaffolds showed rapid and inhomogeneous
degradation. After 6 weeks, a clear degradation layer
(score 2) was visible with detachment of increased
small and occasionally large scaffold particles (score
2 and 3). A single La2 scaffold was already completely
degraded (score 4). More than 50% of the La2 scaf-
folds were degraded after 12 weeks (score 3; with one
exception, score 2), and large portions of the scaffolds
were separated (score 3). From 24 weeks onwards, all
La2 scaffolds (with one exception, week 24, score 3)
were completely degraded and the shape of the scaf-
fold was no longer recognizable (score 4). Overall, the
La2 scaffolds showed significantly faster degradation
and loss of shape in all week groups compared to the
LAE442 scaffolds (p < 0.001).
In contrast to the TCP control group, accumula-
tion of gas could be detected in the scaffolds made
from the twomagnesium alloys. The highest accumu-
lation of gas was found in La2 after 12 weeks. More
than 50% of the internal space (pores) was filled with
gas and more than 50% of the direct surface was sur-
rounded by gas. Subsequently, at week 24 only small
amounts of gas were observed and at week 36 no
gas was found. In contrast, LAE442 showed a relat-
ively constant gas accumulation directly around the
scaffolds, which covered at least 25% and sometimes
more than 50% of the surface, over all observation
times. Within the LAE442 scaffolds, more than 25%
and up to 50% of the interstices were filled at the early
implantation points, and mainly small gas bubbles
were observed at the later implantation points.
In all time groups, bone in the vicinity of the
LAE442 scaffolds mainly showed a mixture of thick
and thin trabeculae, which was more pronounced
in the upper half of the scaffolds near the drill hole
(figure 5(a)). In the lower part near the medullary
6
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Figure 4. µCT80 images: (a) LAE442 scaffold 36 weeks after implantation, arrow: bright appearing deposits (Ca/P) on scaffold
surface; (b) La2 scaffold 6 weeks after implantation, star: narrow-meshed bone trabeculae.
Figure 5. Semi-quantitative analysis of the µCT80 scans showing the parameters after the implantation periods of 6, 12, 24 and
36 weeks: (a) structure of surrounding bone, (b) scaffold integration into bone, (c) bone in outer ring and (d) bone in inner ring;
score values ranged from 0 for physiological/original to 4 for clearly altered (table 1).
canal, thin, narrow-meshed bone trabeculae and
occasionally only small bone particles could be
observed around the LAE442 scaffolds. The struc-
ture of the cancellous bone around the La2 scaf-
folds was very inhomogeneous. In all week groups,
often only very small bone fragments and in some
cases a mixture of mostly thin and thick trabeculae
occurred (figure 5(a)). In some cases of the 6—and
36—weeks group, no bone was found in the vicinity
of the La2 scaffolds. An increased occurrence of thin,
narrow-meshed bone trabeculae was observed after
12 and 24 weeks (figure 5(b)). The TCP control group
showed mainly a widely cross-linked, spongy bone
and occasionally a mixture of thick and thin trabecu-
lae in all time groups (figure 5(a)).
For the parameter ‘integration of scaffold into
bone’, LAE442 showed an average of one direct con-
tact per cross-section at all observation times, with
7
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a slight increase after 36 weeks. Although several
bone trabeculae and in some cases large bone bridges
occurred around most of the LAE442 scaffolds, these
did not have direct contact to the scaffold but were
separated by narrow gaps. However, isolated LAE442
scaffold areas also showed larger distances to the
surrounding cancellous bone (figure 5(b)). The La2
scaffolds also showed on average one direct con-
tact per cross-section after 6 and 12 weeks. Com-
pared to LAE442, the distances between the sur-
rounding cancellous bone and the La2 scaffolds were
considerably larger. In the La2 week group 24 and
36, increased contact between a few bone trabeculae
and the degraded scaffold residues could be detected
(figure 5(b)). The TCP implants showed close contact
to the cancellous bone through several bone trabecu-
lae punctuated with isolated gaps at all observation
times (figure 5(b)).
For the parameter ‘bone in the scaffold’, about
2%–5% bone was observed in the LAE442 scaffolds
after 6 weeks in 5/10 scaffolds in the outer ring and
about 1% bone in 3/10 scaffolds in the inner ring
(figures 5(c) and (d)). In the remaining LAE442 scaf-
folds, no bone could be found after 6 weeks. At
the subsequent implantation points, bone ingrowth
in the pores became increasingly inhomogeneous,
with the majority showing no bone or isolated small
bone fragments in the outer area. However, in a
few samples up to 10% bone within the pores of
the LAE442 scaffolds could be observed. In com-
parison, no bone within the pores could be detec-
ted after 6 and 12 weeks in the La2 scaffolds. After
24 and 36 weeks, about 2%–5% bone in the outer
area between the degraded scaffold residues could
be observed. In the inner area, small bone trabec-
ulae occurred only in single cases after 24 weeks of
implantation. After 36 weeks, no bone was visible in
the centre (figures 5(c) and (d)). The TCP implants
showed the best values within the pores after 6 and
12 weeks, with an average of about 6%–10% bone in
the outer ring and 2%–5% in the inner ring. After 24
and 36 weeks, TCP had over 10% bone in the outer
ring and about 6%–10% in the inner ring (figures 5(c)
and (d)).Within theTCP implants, significantlymore
bone was found at all observation times than in the
magnesium scaffolds (p<0.001). LAE442 showed sig-
nificantly more bone in the outer ring after 6 and
12 weeks (p < 0.001) in comparison to La2. At the
original implantation site of La2, significantly more
bone was observed after 24 and 36 weeks (p < 0.001)
as compared to LAE442.
3.1.2. Quantitative µCT80 evaluation
Due to the almost complete degradation of the La2
scaffolds after 24 and 36 weeks, the quantitative eval-
uations for these scaffolds could only be performed
for the observation times 6 and 12 weeks.
Continuous and slow degradation of the scaf-
folds was observed in the LAE442 group, which was
accompanied by a volume loss of 7.46% (2.7 mm3)
by week 36. In comparison, a volume loss of 62.72%
(22 mm3) with inhomogeneous degradation beha-
viour could already be observed in the La2 scaffolds
after 12 weeks. The LAE442 scaffolds showed signi-
ficantly more volume (p= 0.001) as compared to La2
at week 6 and 12. In terms of density, the LAE442
scaffolds showed a slight increase at all observation
times as compared to their original density. A similar
increase in density was observed in the La2 scaffolds
after 6 and 12 weeks (figures 6(a) and (b)).
Analysis of the ingrown bone of LAE442 after
6 weeks revealed an average of 0.55 mm3 bone-
like fractions in the pores of the scaffolds. After
12 and 24 weeks, the proportion of bone in the
pores decreased, and at 36 weeks an average of
0.36 mm3 bone-like fractions within the pores could
be observed (figure 6(c)). In the La2 scaffold, bone-
like fractions averaging 0.05 mm3 after 6 weeks
and small bone fragments averaging 0.19 mm3 after
12 weeks were observed in the outermost region
of the already severely degraded scaffold sections
(figure 6(c)). In the TCP control group, many small
bone trabeculae between the implant residues (aver-
age 24.29 mm3 bone) could be detected after 6 weeks.
At all subsequent observation times, fewer but thicker
bone trabeculae (average 18.64 mm3 bone) occurred,
which enclosed the remaining implant parts.
3.2. Histological examination
In the evaluation of the central cross-section, the La2
scaffolds showed rapid degradation with significantly
less scaffoldmaterial (p< 0.001) after 24 and 36weeks
as compared to LAE442 (figures 7(a)–(h)). In con-
trast, the LAE442 scaffolds remained relatively con-
stant with respect to the amount of material and only
showed an increasing amount of ‘cracked’ degrada-
tion layer until week 36.
Until week 12, LAE442 showed more bone within
the scaffolds in the central cross-section as compared
to La2. After 24 weeks, more bone in the form of
thin bone trabeculae between the La2 residues was
observed as compared to LAE442. These bone trabec-
ulae decreased again after 36 weeks in the area of the
original scaffold localization of La2 (figure 8(b)).
LAE442 in particular showed an increasing
amount of poorly mineralized, osteoid-like bone
matrix within the scaffold pores of more than 25% by
week 24, with an increasing number of empty osteo-
cyte lacunae over time. Between the remains of the
La2 scaffolds, poorly mineralized bone matrix was
also observed after 24 and 36 weeks (figure 8(c)).
After 6 and 12weeks, granulation tissue was rarely
present in La2 and only in the peripheral area of these
scaffolds. The La2 scaffolds showed a strong accu-
mulation of gas within the scaffolds. From week 24
onwards, a small accumulation of gas andmore gran-
ulation tissue between the scaffold residues of La2
were observed. No gas could be detected in La2 after
8
Biomed. Mater. 16 (2021) 035037 N Kleer-Reiter et al
Figure 6. Quantitative µCT80 evaluation of magnesium scaffolds LAE442 and La2: (a) scaffold volume, (b) scaffold density, and
(c) bone within the scaffold pores (La2 scaffolds after 24 and 36 weeks were non-evaluable).
36 weeks (figures 8(a) and (d)). Within the LAE442
scaffolds, the low to moderate gas accumulation as
well as the amount of granulation tissue (<10%),
which was also found in the scaffold centre, decreased
slightly over the observation period (figures 8(a)
and (d)). After 24 and 36 weeks, LAE442 showed
significantly less granulation tissue (p < 0.001)
and after 36 weeks significantly more gas (p < 0.001)
compared to the La2 scaffolds. In the TCP con-
trol group, no gas in and around the scaffolds
and more than 25% granulation tissue within the
implants could be observed at all time groups
(figures 8(a) and (d)).
After 6 and 12weeks, half of the La2 cross-sections
were surrounded by up to 50% by gas and in the other
half over 50% of the implant surface was surrounded
by gas. In two cases, after 24 weeks up to 25% of the
remaining scaffold material was still covered by gas
and after 36 weeks no gas was found around the La2
residues. In the LAE442 scaffolds, the gas accumula-
tion in the direct vicinity of the scaffold remained rel-
atively constant at all observation times between 25%
and 50% (score 2) and over 50% (score 3) with amax-
imum after 24 weeks.
Direct bone-to-scaffold contact was observed
only in single LAE442 cross-sections at several sites.
9
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Figure 7. Histological cross-sections of LAE442, La2 and TCP, toluidine blue: (a)–(d) LAE442, (e)–(h) La2 and (i)–(l) TCP;
B= bone, G= gas, O= osteoid-like non-mineralized bone matrix, S= scaffold material (magnesium), I= implant material
(TCP), FC= fibrous capsule, D= debris, C= cell cluster.
Figure 8. Results of the histological evaluation (25×magnification) within the scaffold (4 mm diameter circle): (a) gas, (b) bone,
(c) non-mineralized bone matrix, and (d) granulation tissue.
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Figure 9. Histological images, toluidine blue: (a), (b) LAE442 after 6 weeks, (c) LAE442 after 24 weeks, (d), (e) La2 after 12 weeks
and (f) La2 after 36 weeks; S= scaffold, SD= scaffold debris, DL= degradation layer with cracks, B= bone, TB= trabecular
bone, G= gas, GT= granulation tissue, OLB= osteoid-like bone matrix, FC= fibrous capsule, FT= fibrous tissue, C= cell
cluster (macrophages and FBCs; marked with white dotted line), MΦ=macrophages (marked with black brace), black
arrows= blood vessels.
In the majority of the LAE442 scaffolds, a connection
between the scaffold material and the surrounding
bone could be demonstrated via a poorly mineral-
ized bone matrix (figure 9(a)). The proportion of
the poorly mineralized bone substance surrounding
the scaffold surface increased significantly over time.
In La2, direct contact between the scaffold and the
surrounding bone by isolated bone trabeculae was
observed in individual cases after 6 and 12 weeks.
Otherwise, strong resorption of the surrounding can-
cellous bone was visible. After 24 and 36 weeks,
the remaining La2 scaffold residues were directly
enclosed by bone.
A fibrous capsule formation around the scaffolds
was observed in La2 in varying degrees after 6 and
12 weeks (figures 9(d) and 10(a)). In addition, a
strong network of thin trabeculae formed behind and
between the fibrous tissue at some distance from the
scaffolds (figure 9(e)). In comparison, only a mod-
erate number of fibrocytes in the granulation tissue
could be detected in LAE442 (figure 10(a)).
In the LAE442 scaffolds, a moderate number
of blood vessels was found after 6 and 12 weeks
(figures 9(b) and 10(b)), with slightly fewer blood
vessels in the centre of the scaffolds as compared to the
peripheral area. Subsequently, after 24 and 36 weeks,
the number of blood vessels decreased and only a few
were present within the scaffolds (figures 9(c) and
10(b)). In the La2 scaffolds, no or only isolated blood
vessels could be observed in the marginal area of the
scaffolds after 6 and 12 weeks of implantation. After
24 and 36 weeks, few blood vessels appeared between
the La2 residues. TCP showed a moderate number of
blood vessels within the implant residues in all time
groups (figure 10(b)).
LAE442 demonstrated an overall increasing but
moderate number of macrophages and a few FBCs
in and around the scaffolds over the entire observa-
tion period. In La2, no macrophages and FBCs were
observed in the central or middle area of the scaffolds
after 6 and 12 weeks. However, an increasing num-
ber of macrophages and FBCs occurred in the imme-
diate vicinity of the La2 scaffolds (figures 10(c) and
(d)). From week 24 onwards, a strong accumulation
of macrophages and FBCs was observed in the centre
of the original scaffold localization (figure 9(f)). The
TCP control group showed no foreign body reaction
(macrophages and FBCs) and had sporadic neutro-
phil granulocytes. Overall, no signs of an inflammat-
ory reaction could be observed in anymaterial group.
3.3. SEM/EDX
The SEM images of LAE442 revealed a darker degrad-
ation layer with increasing extent over time with
an accumulation of calcium and phosphorus [2].
In some places the degradation layer had a double-
layered structure with a bright outer and a darker
underlying part (figures 11(a) and (b)). Comparing
these two layers, the darker layer had a higher mag-
nesium content and the brighter layer had a higher
calcium and phosphorus content (table 3). On the
scaffold surface of LAE442, fluorine, a component
of the MgF2 coating, could be detected to vary-
ing extents depending on localization and implant-
ation period. A general decrease could be observed
to 0.8 wt.% fluorine after 36 weeks. Furthermore,
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Figure 10. Results of the histological evaluation (100×magnification) within the scaffold: (a) fibrous cells, (b) blood vessels,
(c) macrophages, and (d) FBCs in the scaffold.
the contact between the scaffold material of LAE442
and the surrounding bone was often observed via an
intermediate matrix with calcium and phosphorus
as the main components (table 3). This scaffold-
matrix-bone connection was increasingly observed
in the implantation periods of 24 and 36 weeks
(figures 11(c) and (d)).
In the La2 scaffolds, the scaffold material and
the strongly increasing degradation layer could be
identified in the SEM images only until 12 weeks
after implantation. Thereby fluorine was detected on
the scaffold surface with 22.8 wt.% after 6 weeks
and 1.6 wt.% after 12 weeks. From week 24 on,
small degraded scaffold particles, as well as bone and
clusters of small, roundish structures (identified on
the histological sections as cell clusters of macro-
phages and FBCs) could be observed in the original
implantation area using SEM images (figures 11(e)
and (f)). Within the described cell clusters, the EDX
analysis of a La2 cross-section after 36 weeks showed a
strong accumulation of lanthanumof up to 67.3 wt.%
(table 3).
4. Discussion
The objective of the present study was to compare the
biocompatibility, the ingrowth of the surrounding
tissue and the degradation behaviour of the mag-
nesium scaffolds La2 and LAE442 with defined inter-
connecting pores in vivo. Commercially available por-
ous β-TCP implants of the same dimensions served
as a control group. So far, the alloy LAE442 has
been investigated in many in vivo studies only as
solid implants, such as intramedullary pins or screws
[27–29]. The binary alloy Mg-La2 exhibited good
properties in vitro, allowing the investigation of this
alloy in vivo [32]. Previous investigations focused
mainly on magnesium scaffolds with a random and
irregular pore distribution [7, 33, 40, 44, 47]. In
order to increase the reproducibility and stability
of the implants, magnesium scaffolds with defined
pore structures were developed for this study. In vitro
investigations by Julmi et al showed sufficient stability
of the open-pored magnesium scaffolds LAE442 and
La2 to withstand the forces occurring in the rabbit
bone [41]. In the study by Kleer et al, these two alloys
LAE442 and Mg-La2 were examined in vivo in the
form of open-pored magnesium scaffolds in the rab-
bit model by means of clinical, radiological and µCT
analyses, and LAE442 in particular showed a slow and
homogenous degradation [43]. In the present in vivo
study, each bone-scaffold compound was examined
in more detail after the respective observation time of
6, 12, 24 or 36 weeks using high-resolution µCT80
scans. In addition, histological examinations were
conducted to assess biocompatibility and EDX ana-
lyses were performed on cross-sections to evaluate the
distribution of elements in areas of special interest.
Using ex vivo µCT80 scans, the degradation of the
scaffolds could be assessed in higher resolution com-
pared to the in vivo µCT images of the study by Kleer
et al [43]. The ex vivo scans revealed the degradation
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Figure 11. SEM and histological images: (a), (b) SEM images of LAE442 after 24 weeks, degradation layer, double-layered
structure with bright outer (1) and darker underlying (2) part; (c) LAE442 after 36 weeks (d) magnification: intermediate
matrix (4) as contact between bone (3) and scaffold (5); (e) La2 after 36 weeks: large cell clusters (macrophages and FBCs),
(f) magnification: roundish structures with bright particles; positions (1–6) marked in (b), (b) and (f) indicate the locations of
the EDX analyses presented in table 3.
layer and bright deposits on the scaffolds. These
bright deposits were probably the accumulation of
calcium and phosphorus, as verified in the EDX ana-
lyses of the LAE442 scaffolds. In the µCT80 images
of LAE442 fine gaps were often visible between the
surrounding bone trabeculae and the scaffold, which
could not be detected in the in vivo investigations by
Kleer et al [43]. Using the histological sections these
apparent gaps could be determined as an osteoid-like
bone matrix. As described in other studies, this was
a poorly mineralized bone matrix and therefore did
not appear bone dense in the µCT80 images [33, 48].
As a result, less frequent direct bone-to-scaffold con-
tacts were evaluated for LAE442 in the present study
compared to the study by Kleer et al [43]. As in the
in vivo study [43], one direct bone-to-scaffold contact
per cross-section was observed on average for the La2
scaffolds. In most cases, one thick bone trabeculae
grew from the periphery directly to the La2 scaffolds
with otherwise large gaps to the surrounding cancel-
lous bone. This observation of inhomogeneous integ-
ration also occurred in the study by Lalk et al on
porous AX30magnesium scaffolds with CaP-coating.
Many of the scaffolds had completely lost contactwith
the surrounding cancellous bone and exhibited wide
gaps [33].
In the µCT80 images, isolated bone dense islands
within the pores of the LAE442 scaffolds were
observed, most of which had no direct contact to the
scaffold material. This phenomenon of isolated bone
islands was also observed by Lalk et al within the
pores of theMgF2-coated AX30 scaffolds. These bony
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Table 3. EDX data for LAE442 and La2 scaffolds: LAE442 after 24 weeks, degradation layer, dark part (position 1) and bright part
(position 2); LAE442 after 36 weeks, bone-to-scaffold contact, bone (position 3), intermediate matrix (position 4), scaffold (position 5);
La2 after 36 weeks, cell clusters, within a cell (position 6); positions 1–6 are marked in figure 10.
Concentration in wt.%
LAE442 24 weeks LAE442 36 weeks La2 36 weeks
Element 1 2 3 4 5 6
Mg 72.7 32.0 7.8 23.1 89.2 1.0
Al 12.9 4.5 0.7 2.6 3.4 1.6
La 0.2 — — — 0.6 67.3
Ce 1.3 2.0 — — 1.1 —
Si 0.3 0.2 0.8 0.2 0.5 —
P 3.8 17.7 26.3 17.6 1.6 18.7
Ca 6.8 41.4 62.4 53.9 3.0 9.2
Na 1.1 2.2 1.6 2.5 — —
S 0.1 — 0.4 — 0.6 1.1
K — — — — — 0.2
Fe — — — — — 1.0
Mn 0.4 — — — — —
Cl 0.4 — — 0.2 — —
islands were surrounded by poorly mineralized bone
matrix which did not appear bone dense in µCT80
[33]. The presence of poorly mineralized bone mat-
rix could be confirmed in the present study using the
histological sections.
In assessing the structure of the surrounding
bone, TCP mainly showed a physiological wide-
meshed bone structure, as also observed in the con-
trol group ‘empty drill holes’ after 12 and 24 weeks in
the study by Lalk et al [33]. This wide-meshed bone
could only be observed after 24 weeks around the
AX30 MgF2-coated scaffolds and only in half of the
CaP-coated scaffolds [33]. The remaining CaP-coated
scaffolds showed only a narrow-meshed bone struc-
ture at 24 weeks [33], which could also be observed
within a certain range around the La2 scaffolds after 6
and 12 weeks. In comparison, the LAE442 scaffolds in
the present study exhibited a better bone structure in
the immediate vicinity with mostly a mixture of thin
and thick trabeculae and only a few large gaps.
µCT80 images of the bone-scaffold compounds
showed, accumulation of gas within and directly
around the magnesium scaffolds, but not in the
TCP control group. During the degradation of mag-
nesium, hydrogen is formed, which accumulates if it
cannot be sufficiently absorbed or removed by the
surrounding tissue and blood vessels [13, 20]. How-
ever, in the in vivo study by Kleer et al and in other
studies, the accumulation of gas inside the bone had
no clinical effects such as lameness or signs of pain on
the animals [43, 49, 50].
The histological evaluation of implants is one
of the most important methods for assessing their
biocompatibility [51]. In the present study, as well as
in many other studies [44, 52, 53], parameters such
as newly formed bone and osteoid, the amount of
blood vessels and fibrous tissue, as well as inflammat-
ory reactions and foreign body reactions (particularly
evident in the presence of macrophages and FBCs)
were examined.
In addition, the evaluation of the scaffold mater-
ial in the present histological examination revealed
‘cracks’ in the degradation layer of the LAE442 scaf-
folds to an increasing extent over the implanta-
tion periods. Ullmann et almicroscopically observed
cracks on the implant surface of LAE442 pins after an
implantation period of 6 months [30]. In the study
by Rössig et al, cracks in the degradation layer of
the LAE442 implants in the sheep model were vis-
ible in the histological sections after 24 weeks [54].
As early as 1900, while investigating Mg implants for
vascular surgery, Payr reported a rough surface on
the implants after 24 h and many furrows and cracks
in the implants after three to four days up to the
complete dissolution of the metal [55]. However, the
‘cracks’ in the present study could also be artefacts
formed in the more unstable degradation layer dur-
ing the preparation of the histological samples. In the
study by Kraus et al, cracks in the oxide layer of Fe-
based implants were attributed to dehydration during
sample preparation [56]. Subsequent investigations
are necessary to clarify this phenomenon and the pos-
sible impact on the stability of the scaffolds.
More bone within the scaffolds was found in
LAE442 compared to La2 by week 12. Small, thin
bone trabeculae were detected after 24 weeks in the
original scaffold localization of La2, after only resid-
uals of the scaffolds and hardly any gas remained.
This phenomenon of regeneration of the surround-
ing bone was also observed in the study by Kraus et al
after almost complete degradation of ZX50 implants
and thus decreasing gas formation [57].
In the present study, an increasing amount of
poorly mineralized, osteoid-like bone matrix was
found over the implantation periods, especially
within the pores of the LAE442 scaffolds. A few pores
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of LAE442 were completely filled with this poorly
mineralized bone matrix. The study by Lalk et al also
revealed unusually wide osteoid formations of up to
220 µm in the area of porous AX30 magnesium scaf-
folds [33]. To a lesser extent, this was also observed in
the original scaffold localization of the La2 scaffolds
after 24 and 36 weeks in the form of thin, poorly min-
eralized trabeculae. Significantly more osteoid com-
pared to the control groupwas also found in the study
by Witte et al in the peri-implant area around the
porous AZ91D scaffolds [40]. Besides other factors,
the fluoride in the coating could lead to increased
osteoid formation by stimulating osteoblastic activ-
ity and delay the mineralisation of new bone. This
mechanism was described by Mousny et al after oral
application of fluoride in a mouse model [48]. Fur-
thermore, there is a controversial discussion in the lit-
erature about whether aluminium, which is a com-
ponent of the LAE442 alloy, has a negative influence
on mineralisation and delays this process [58–60].
The exact mechanisms of incomplete mineralization
could not be conclusively clarified in this study. How-
ever, it appears to be a multifactorial process, since
the osteoid-like bonematrix was present in bothmag-
nesium alloys to a different extent.
Within the pores of LAE442 scaffolds, a moderate
number of blood vessels could be detected histologic-
ally in the early time groups (6 and 12 weeks), as well
as within the TCP implants at all implantation times.
In contrast, no blood vessels were found within the
La2 scaffolds after 6 and 12 weeks and subsequently
(24 and 36 weeks), as with the LAE442 scaffolds, only
a few blood vessels were observed. Vascularisation in
the area of the bone graft substitutes is of critical
importance for osseointegration [9]. In the study by
Cheng et al, the 400 PMg scaffolds with the larger
pores in a rabbitmodel showed higher vascularisation
compared to the smaller pore size, which could be the
reason for the increased bone formation [47]. Over-
all, the TCP control group showed the best vascular-
ization and osseointegration in the present study, as
well as the largest amount of ingrown bone compared
to both magnesium scaffolds. However, the mechan-
ical properties such as the stability of β-TCP are not
sufficient for the application in weight-bearing bone
defects [12].
The presence of macrophages and FBCs, as well
as the formation of granulation tissue, is considered
to be a normal response to implanted degradable
biomaterials [4]. In the long-term study by Angris-
ani et al, investigating intramedullary LAE442 pins
in a rabbit model, the presence of macrophages and
giant cells for removal of corrosion products of the
LAE442 pins was assessed as good cellular compatib-
ility [26]. Therefore, the mild to moderate presence
of macrophages and FBCs in the LAE442 scaffolds
is considered as a normal reaction to the biomater-
ial during the degradation process and indicates good
biocompatibility. In comparison, no or hardly any
granulation tissue and thus no cells were detected due
to gas within the pores of the La2 scaffolds after 6 and
12 weeks. Subsequently, a very strong accumulation
of macrophages and FBCs was observed in the ori-
ginal scaffold localization of the La2 scaffolds after 24
and 36 weeks, partially surrounded by fibrous tissue.
Only amoderate number of fibrocytes occurred in the
granulation tissue of the LAE442 scaffolds, but there
was no capsule formation. In comparison, the La2
scaffolds in the present study showed an overly rapid
degradation, associatedwith a distinct fibrous capsule
formation after 6 and 12 weeks. This formation of a
fibrous capsule around a biomaterial is induced by the
body to protect the surrounding host tissue [4]. Fur-
thermore, in the present study, the increased accumu-
lation of gas around the La2 scaffolds may also have
influenced the extent of capsule formation. According
to the study by Nuss et al, the combination of a thick
fibrous capsule and a high number of macrophages
and FBCs indicates insufficient biocompatibility [4],
as can be assumed for the La2 scaffolds.
In addition, the EDX analysis in the area of these
cell clusters (macrophages and FBCs), which were
observed in La2 scaffolds after 36 weeks, showed
an increased concentration of lanthanum of up to
67.3 wt.%. Free lanthanides have an affinity to accu-
mulate in the bone due to their similar physicochem-
ical properties to calcium [61]. A progressive loss of
membrane integrity in macrophages was observed in
the in vitro study by Southwick et al after exposure to
lanthanum [62]. Feyerabend et al reported a reduc-
tion in cell viability of the macrophage cell line RAW
264.7 after a lanthanum exposure time of 24 h [63].
Thus, the large clusters of macrophages and FBCs in
the original scaffold localization of La2 could prob-
ably be associated with apoptosis of these cells due to
the lanthanum accumulation.
Furthermore, the MgF2 coating was investigated
by means of EDX analysis. In the present study, about
2/3 of the original fluoride disappeared from the
scaffold surface after 6 weeks and hardly any flu-
oride could be detected after 12 weeks. In contrast,
Witte et al described less than 1 wt.% fluoride on
the implant surface after only 4 weeks and thus a
complete disappearance of the initial MgF2 coating
(thickness 150–200 µm) on the LAE442 implants
[29]. Despite the same alloy and coating manufac-
turing process, fluoride lasted longer in the present
study than by Witte et al, although the initial coat-
ing was much thinner. Subsequent studies with more
frequent investigation time points would be neces-
sary to accurately evaluate the reduction of corrosion
provided by the MgF2 coating.
The EDX analysis of the LAE442 scaffolds showed
both an accumulation of calcium and phosphorus in
the degradation layer and a deposition of both ele-
ments on the scaffold surface, as already described
earlier [2]. This fact could explain the increas-
ing density of the LAE442 scaffolds observed in
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µCT80 over time. In many other in vivo studies,
this accumulation of a mineralized phase of calcium
and phosphorus in the degradation layer of mag-
nesium implants has been observed [30, 35, 64].
In the present study, these deposits of calcium and
phosphorus on the LAE442 scaffolds showed direct
contact to the surrounding bone, also described by
Witte et al for porous AZ91D scaffolds in a rabbit
model [13].
5. Conclusion
In summary, the present study showed an
inhomogeneous and fast degradation for La2. In
addition, the La2 scaffolds exhibited an inadequate
osseointegration with fibrous capsule formation in
the early implantation periods and a foreign body
reaction at later implantation periods. LAE442, on the
other hand, showed direct bone-to scaffold contact,
a homogeneous degradation behaviour and almost
maintained its original shape up to 36 weeks. Within
the pores of the LAE442 scaffolds vascularization,
moderate cellular response, as well as granulation
tissue and bone were observed at all implantation
periods. Furthermore, osteoid-like bone matrix was
detected on the scaffold surface and within the pores
of LAE442. Based on the results of this study, por-
ous LAE442 showed promise as degradable scaffolds
for bone defect repair in terms of degradation beha-
viour and biocompatibility. However, further stud-
ies are needed to show it would have the necessary
mechanical properties required over time for weight-
bearing bone defects. Moreover, additional coatings
(for example CaP) could further delay the degrada-
tion rate and gas production andmight have a positive
effect on the mineralisation of the osteoid-like bone
matrix.
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